 At the time of Baldino's death in 2010, the company he had co-founded in 1987 was best known for 
the alertness drug Provigil, the painkiller Actiq, and the seizure disorder medication Gabitril.In 2011, Cephalon agreed to acquire ChemGenex Pharmaceuticals, which would provided Cephalon with marketing rights to Omapro, a therapeutic agent for a drug-resistant leukemia, in the oncology therapeutic area.Longtime chief financial officer J. Kevin Buchi succeeded Baldino as CEO in 2011.